Purpose: A newly developed synthetic αvβ3 integrin targeted optical probe (ITOP) has been demonstrated to target cancer cells, in vivo. Compared to the commercially available cyclic peptide c [RGDfv], this optical probe has at least 20 times better binding affinity for the αvβ3 receptor. The present in vitro study was designed to investigate the possibility of detecting early atherosclerotic plaque by using this ITOP. Procedures: Experiments were performed on five Watanabe heritable hyperlipidemic rabbits and two New Zealand White rabbits for control. Our ITOP was used for detecting the presence of αvβ3 receptors in vitro. Results: Segments of plaque accumulation from two distinct regions of ascending and descending aortas were labeled in Watanabe rabbits. The signal was found principally in the adventitia and proximal intima of the aortic vessel, corresponding directly to the expression of integrin αvβ3 as determined by antibody assay. Moreover, there was a close association between the level of labeling with the αvβ3 targeted probe and the thickness of the adventitia. Conclusions: This high-affinity ITOP identifies the site and extent of αvβ3 expression and correlates with adventitial thickness. Recent evidence associates αvβ3 expression with the inflammatory process in early vulnerable plaque, making this compound a promising potential biomarker for early atherosclerotic disease.
Introduction
D espite all the recent technological and medical advances, cardiovascular disease remains the leading cause of death in the Western World and needs to be detected at an earlier stage [1] . With the understanding of atherosclerosis as an inflammatory disease [2, 3] , there is a growing interest in the detection of components of the inflammatory process as early biomarkers of this disease. One potential promising molecular target for the detection of atherosclerotic plaque is the αvβ3 receptor [4, 5] , which is a widely recognized target for the development of molecular probes in pathological conditions [6, 7] . In addition, human atherosclerosis lesions show extensive expression of αvβ3 [8] , which plays a role in thrombus formation [9] , cell migration [10] , neovascularization [7, 11] , as well as many other processes. Although αvβ3 is expressed on a variety of cells, its expression seems to be predominant in smooth muscle cells and endothelial cells [8, 12] . Macrophages also express αvβ3 during foam cells formation [13] . Most interesting is the fact that αvβ3 expression seems to be an early event in plaque formation [5, 14] and is also correlated with plaque instability [4, 15] . Additionally, previous studies have shown the great potential of targeting αvβ3 integrin for the development of contrast agents that enhance the detection of plaque [16, 17] and for the delivery of therapeutic drugs [18] .
Recently, an integrin targeted optical probe (ITOP) was synthesized and has been shown to efficiently target the αvβ3 receptor with high affinity in an in vivo mouse model of cancer [19] . The probe is a small non-peptidic carbamate integrin antagonist (RGD mimic), which is fluorescently labeled and targets the αvβ3 integrin. Compared to nanoparticles having sizes of hundreds of nanometers (nm), this probe is much smaller (G1 nm), which should translate into better clearance from blood and better diffusion into the targeted tissue. In vitro, this labeled compound has very high affinity for αvβ3 (IC 50 of 3 nM) and greater selectivity towards αvβ3 compared to αIIbβIIIa, αvβ5, and αvβ6 (IC50>100µM) [19] . This ITOP has at least 20 times higher binding affinity for αvβ3 compared to the commercially available cyclic peptide c [RGDfv] labeled with fluorescein isothiocyanate (FITC; personal communication, Narasimhan Danthi). When intravenously injected in tumor bearing mice, the ITOP persisted in the tumor for more than 4 h, while it disappeared from most of the other tissues within an hour, demonstrating that its biodistribution is conducive for use in imaging. Based on these animal experiments [19] , we have not seen immunogenic reactions associated with our ITOP. As a first step, in this in vitro study, we have explored the utility of this ITOP to probe the molecular processes involved in atherosclerotic plaque formation, in a Watanabe rabbit model.
Materials and Methods

Integrin αvβ3 Targeted Optical Probe Synthesis
The αvβ3 ITOP 4-[2-(3,4,5,6-tetrahydropyrimidin-2ylamino)ethyl-oxy] benzoyl-2-(S)-[N-(3-amino-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine fluorescein thiourea (Fig. 5 , suppl. data) was synthesized as previously described. Briefly, ITOP was developed from a potent fibrinogen receptor antagonist (3-amino-2(S)-arylsulfonylaminopropionic acid derivative) [20] with further structural modifications, followed by conjugation to FITC. The conjugation of the fluorophore to the integrin antagonist did not alter the binding affinity or selectivity to integrin αvβ3. This compound represents the first example of a nonpeptidic integrin αvβ3 targeted optical probe. In the binding assays as well as in the cell adhesion inhibition assays this compound showed very high binding affinity (3nM) and selectivity to αvβ3 compared to αIIbβIIIa, αvβ5, and αvβ6 [19] .
Experimental Design
All experiments were performed on specimens taken from 3-to 12-month-old Watanabe heritable hyperlipidemic (WHHL) rabbits, two females and three males (n=5), fed a standard rabbit chow diet. The animals were purchased from Brown Family Enterprises (Gemini Research of Alabama, Odenville, Alabama, USA). Control aortic tissues without atherosclerosis were taken from New Zealand White (NZW) rabbits (n=2) and purchased from Zyagen (San Diego, CA, USA). Prior to any experiments, rabbits were anesthetized with a ketamine (30 mg/kg) and xylazine (5 mg/kg) cocktail administered subcutaneously and then euthanized by intravenous pentobarbital (100 mg/kg) injection while still under anesthesia. The aortic arch was excised and cut into different sections prior to be quick frozen in optimal cutting temperature (OCT) media for histological and immunohistological experiments. All experiments were performed in accordance with protocols approved by the Animal Care and Use Committee of the National Heart Lung and Blood Institute.
Histology
OCT blocks from frozen aortic tissue were cut into 7-8-µm sections with a cryostat and mounted onto slides. Routine hematoxylin and eosin (H&E) straining was performed on the frozen sections. An antibody against human αvβ3, anti-human integrin αvβ3, clone LM609 (Chemicon International, Temecula, CA, USA), was used to confirm the presence of the integrin and as a reference for the localization of any experimental fluorescence signal. This antibody was used in conjunction with an anti-mouse horseradish peroxidase detection kit, according to the specifications of the company (Chemicon International). Expression of αvβ3 integrin in the aortic wall was assessed by immunohistofluorescence with the new ITOP. Sections were thawed for 15 min at room temperature, fixed for 10 min with cold acetone, washed in phosphate buffer solution, and then incubated with the targeted fluorescent probe for 1 h. After the incubation period, the slides were washed again, mounted with VECTASHIELD mounting medium containing DAPI (Vector Laboratories, Burlingame, CA, USA) and a coverslip was applied. For signal specificity experiments, slides were incubated with the unlabeled ITOP prior to the washing and mounting steps. Images of staining or fluorescence signal were acquired under a microscope (Nikon E1000 with a Nikon DXM-1200 color camera) using a visible or ultraviolet light source, respectively.
Results
Plaque Labeling
Histological staining (H&E) of WHHL rabbit aortic tissue demonstrated intimal thickening, which was absent in the control. Examination of the aortic tissue incubated for 1 h with the ITOP showed a strong fluorescent signal (Fig. 1a) . Aortic tissue that has been incubated with non-labeled ITOP showed a loss of signal (Fig. 6 , suppl. data). Signal enhancement was predominately localized in the adventitia and the neointima, though there was also some fluorescence in the media. In contrast, the specific fluorescent signal of the integrin targeted probe was absent in the control NZW rabbits (Fig. 1b) . There was some autofluorescence in the aortic tissue, but it was negligible.
Signal Correlation with an Anti-αvβ3 Antibody
A transverse image of the ascending aorta of the WHHL rabbit shows that the intimal thickening (neointima) of the tissue is a component of the atherosclerotic plaque (Fig. 2) . Upon comparison, the immunohistological labeling of αvβ3 (Fig. 2, right panels) and the fluorescence signal of the ITOP (Fig. 2 , left panels) appear co-localized to the same regions. Higher magnification (×100) of the neointimal region (Fig. 2c, d ) demonstrated corresponding strong fluorescence and immunohistological signals near the interface of the lumen and intima. The fluorescent and immunohistological labeling are mostly localized in the adventitia and proximal intima of the ascending aorta; a similar distribution was shown in the descending aorta sections (Fig. 1) .
Adventitia Labeling
Higher magnification images of the adventitial sections demonstrated co-localization between the ITOP signal and the DAPI (4′,6-diamidino-2phenylindole) labeling of cell nuclei, suggesting that the signal from the fluorescent molecule is found close to the nucleus of the cell (Fig. 3) . Adventitial co-localization results also showed neovessellike structures, located around regions delineated by cells labeled with fluorescent ITOP.
Labeling and Adventitia Thickness
Comparison between fluorescent staining with the αvβ3 targeted probe (Fig. 4, upper panel) and histological staining (Fig. 4, bottom panel) of the corresponding descending aorta section demonstrates a qualitative correlation between fluorescent signal intensity and adventitial thickness. Thus, a mild signal was present in plaques with a small adventitia thickness (Fig. 4a, b, d, e) , while a strong signal appeared on plaque with marked adventitia thickness (Fig. 4c, f) . There is also some inverse correlation between the intensity of fluorescence labeling and the organization level of the plaque. Staining was very intense (Fig. 4c) when the media was disorganized (Fig. 4f ) and less intense (Fig. 4a, b) when the media was well delineated (Fig. 4d, e) . 
Discussion
Integrin expression, particularly αvβ3, in atherosclerotic plaque is a critical component of the inflammatory process that can drive the plaque toward a more unstable state [21, 22] leading to plaque rupture [23] [24] [25] . Many processes taking place during the initiation and progression of inflammatory vascular lesions require αvβ3 expression, including foam cell formation [13] , smooth muscle cell migration [26] , and thrombus formation [9] .
In this study, we describe the use of a novel synthetic high affinity and high specificity αvβ3 integrin targeted optical probe and confirmed the in vitro specific labeling of rabbit atherosclerotic plaques (Figs. 1 and 2) . We also show that the ITOP signal is localized near the nucleus of the cell (Fig. 3) , which indicates that fluorescence is correlated to cells (αvβ3 receptors are membrane-bound) instead of unspecific ECM labeling. One interesting observation in the present work is that the fluorescent signal of the integrin targeted optical probe seems to extend from the adventitia toward the media of the aortic wall (Fig. 1a) . The presence of fluorescent signal in the media is correlated with strong labeling and expansion of the adventitial layer (Figs. 1a and  3 ). This finding might be associated with the development of the angiogenic processes that first begins within the adventitia (vasa vasorum expansion) and then extends to the media of the vessel wall [27] . Nevertheless, further studies must be carried out to clarify the relationship between our compound and the natural history of angiogenesis in atheroma. Most importantly, there is a strong correlation between the labeling of atherosclerotic plaque with the integrin targeted probe and the thickness of the adventitia (Fig. 4) . Thus, adventitial thickness is characterized by a strong and widely distributed signal enhancement with the probe, which may signal a more advanced inflammatory state. Moreover, stronger αvβ3 labeling is situated where the media is less organized, which is another sign of the presence of inflammation.
In agreement with other studies [5, 8, 16] , we also found that the most significant accumulation of the αvβ3 receptor was in the adventitia of the aortic wall, a privileged site for the formation of neovessels. We also observed a characteristic expansion of the adventitia, a process which has been extensively described by others studies [5, 16, 28, 29] . This expansion allows angiogenesis and will further attract more inflammatory cells and lipids into the plaque, contributing to plaque growth, instability, and rupture.
In addition to the adventitial localization of the signal, we also observed fluorescence within the neointima of plaques, close to the lumen. Previous studies have shown that activated or proliferative endothelial cells express high levels of αvβ3 [7, 11] . This integrin is critical for the survival signal of these cells and is also recognized to influence adhesion and migration pathways [12] . Hence, it is not surprising to observe evidence of αvβ3 within the intima.
With the broad development of nanoparticles in disease detection [30, 31] , we can extrapolate the use of this new αvβ3 integrin targeted probe for imaging atherosclerosis in combination with a variety of high-resolution molecular imaging techniques [32, 33] . The synthetic nature of this molecule makes it attractive for the development of various nanoparticle structures incorporating this molecule to target the plaque. For example, this ITOP was efficiently used in a combined imaging/treatment system for targeted drug mild (a, b) . In a similar direct correlation, for the aorta sections with large adventitia (marked thickening; f), the signal from the αvβ3 targeted probe is marked (c). There was also an apparent inverse correlation between the intensity of labeling and the organization within the plaque. Staining is very intense when the media appears disrupted (c) and less intense when the media is well delineated (a, b). FITC fluorescein isothiocyanate, Ad adventitia, M media, NI neointima. delivery and imaging of cancer angiogenesis [34] . For coronary atherosclerotic plaque assessment, we are working on labeling this ITOP with near-infrared molecules as part of a dual imaging system, which may allow MRI-guided catheter to detect fluorescent probes. This can lead to the delivery of treatments into specific unstable area of the plaque.
Relative to peptide-based molecules, this synthetic probe provides easier production and purification. Moreover, its affinity as a labeled probe for the αvβ3 receptor is higher than the commercially available labeled cyclic peptide c [RGDfv] . This should translate into a smaller injected dose for the plaque detection and also a better sensitivity. In addition, our ITOP is specific to αvβ3, whereas linear and cyclic RGD peptide specificity is broader (αvβ3, αIIbβ3a, αvβ5).
The physiochemical characteristics of this probe are also important. As opposed to antibodies, this small synthetic molecule (G1 nm) has less potential to induce an immune response and has important advantages related to the blood clearance and its diffusion into the targeted atherosclerotic tissue. Moreover, unlike antibodies, the probe is very suitable for further derivatives or structure modifications. However, future in vivo studies will be necessary to evaluate the labeling efficiency and kinetic uptake properties of this new optical probe.
Conclusions
This in vitro work demonstrates that a new high-affinity ITOP identifies the presence of αvβ3 expression associated with early atherosclerotic plaque development in the aortas of Watanabe rabbits. The studies further suggest that the αvβ3 expression identified by this probe corresponds to the degree of adventitial thickening. As such, this new probe holds promise for meeting the challenge of detecting early atherosclerotic lesions and identifying vulnerable plaque.
